Johannes Ettl

发表

Use of Real-Time Rig Sensor Data to Improve Daily Drilling Reporting, Benchmarking and Planning - A Case Study

Wolfgang Mathis, Gerhard Thonhauser, Gerhard Wallnoefer, 2006 .

Dynamische Emissions- und Kraftstoffverbrauchsmessung an pflanzenöltauglichen Traktoren

Heinz Bernhardt, Johannes Ettl, Klaus Thuneke, 2016 .

Use of Real-Time Rig-Sensor Data To Improve Daily Drilling Reporting, Benchmarking, and Planning—A Case Study

Wolfgang Mathis, Gerhard Thonhauser, Gerhard Wallnoefer, 2007 .

Nippel-sparende subkutane Mastektomie (NSSM) als Reduktionsplastik mit deepithelsiertem fasziokutanem Flap, subpektoraler Implanteinlage und Titan-Polypropylennetz-Interponat

Johannes Ettl, Stefan Paepke, E. Klein, 2011 .

Reale Emissionen eines pflanzenöltauglichen Traktors

Heinz Bernhardt, Johannes Ettl, Georg Huber, 2016 .

Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristics

Steven N. Hart, Chunling Hu, Peter A. Fasching, 2018 .

PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.

Johannes Ettl, Jan Gaertner, J. Gaertner, 2017, Annals of palliative medicine.

Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients

Johannes Ettl, Bernhard Haller, Hermann Berger, 2015, European Radiology.

MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease

Johannes Ettl, Markus Oechsner, Jan J Wilkens, 2019, Radiation Oncology.

First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers

Johannes Ettl, Matthias Eiber, Tibor Vag, 2016, The Journal of Nuclear Medicine.

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Xin Huang, Johannes Ettl, Marcus Schmidt, 2015, The Lancet. Oncology.

Future Biofuels and Driving Concepts for Agricultural Tractors

Johannes Ettl, Klaus Thuneke, Peter Emberger, 2014 .